Palbociclib

Palbociclib is a pharmaceutical-grade active ingredient classified as a CDK4/6 Inhibitor and Antineoplastic Agent. Mediocon Inc supplies high-purity Palbociclib API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Palbociclib selectively inhibits cyclin-dependent kinases 4 and 6, blocking cancer cell cycle progression from G1 to S phase. It is primarily used in combination with hormone therapy for the treatment of HR-positive, HER2-negative advanced breast cancer.

Key Features

• High-purity pharmaceutical grade API
• IP/BP/EP/USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing

Applications

• HR+/HER2- breast cancer
• Metastatic breast cancer (combination therapy)
• CDK4/6-driven tumors research
• Oncology formulation development

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings